To study the possible impairment of 11 \g=b\-hydroxysteroid-dehydrogenase in patients with chronic renal insufficiency, urinary excretion rates of the four main glucocorticoid-metabolites, tetrahydrocortisol, tetrahydrocortisone, allotetrahydrocortisol and allotetrahydrocortisone were determined by capillary gas chromatography in 22 patients with chronic renal insufficiency with (N=15) and without (N=7) hypertension, but without hemodialysis treatment. Whereas the sum of all 41 steroid metabolites determined by capillary gas chromatography was reduced (p<0.001) in patients with chronic renal insufficiency as compared with 22 healthy individuals, the relative contribution of the four glucocorticoid metabolites to total steroid excretion was similar in patients with renal insufficiency (22\m=+-\12%)and in healthy subjects (20\m=+-\5%).However, the excreted amount of tetrahydrocortisol exceeded that of tetrahydrocortisone in all but 3 (normotensive) patients with chronic renal insufficiency, but only in one healthy subject resulting, in patients with chronic renal insufficiency, in a ratio of tetrahydrocortisone vs tetrahydrocortisone of 0.7\m=+-\0.4 (hypertensive patients 0.5\m=+-\0.2; normotensive patients 1.1\m=+-\0.4;controls 1.9\m=+-\0.9,p<0.001 vs patients with chronic renal insufficiency). This ratio of tetrahydrocortisone/tetrahydrocortisol showed a correlation with serum concentrations of creatinine (p<0.001). These results provide indirect proof of an impaired conversion of cortisol to cortisone in moderate renal insufficiency and may suggest a relationship with the hypertension frequently seen in this group of patients.The binding affinity of the glucocorticoid cortisol to mineralocorticoid receptors in vitro equals that of aldosterone (1,2). However, in tissues with abun¬ dant activity of 1 lß-hydroxysteroid dehydrogenase (1 lß-OHSD) the potential mineralocorticoid activity of cortisol (2,3) is counteracted by local conver¬ sion of cortisol to the inactive steroid, cortisone (4), which is catalysed by this microsomal enzyme com¬ plex. The fact that the human kidney is an impor¬ tant site for the conversion of cortisol to cortisone (5) explains the aldosterone-selectivity of minera¬ locorticoid receptors of renal origin as opposed to structurally identical receptors located in the hip¬ pocampus and in the heart (1,6). Whereas renal 1 lß-OHSD protects the healthy kidney from the mineralocorticoid actions of cortisol, a defect in the cortisol-cortisone shuttle will cause hypertension. Indeed, congenital deficiency of 1 lß-OHSD, the